Datex FootPrint ® WMS Announces 21 CFR Part 11 Compliance

Datex FootPrint ® WMS Announces 21 CFR Part 11 Compliance

Clearwater, FL, December 08, 2010 --(PR.com)-- Datex, a supply chain software developer, recently announced a major improvement to its WMS product, FootPrint ®. FootPrint® WMS now provides an audit trail and electronic signature, making it compliant with FDA 21 CFR Part 11. This change directly benefits clients in the pharmaceutical, food, medical device, biotech, third party logistics and other industries.

This high level of functionality is typically only found on high end Tier 1 enterprise level warehouse management systems with higher total cost of ownership. By introducing this functionality to FootPrint®, Datex hopes to attract businesses who want leading edge functionality without the high costs typically associated with other Tier 1 software.

Food industry experts often encourage the use of an integrated hardware and software approach in order to create good manufacturing practices (GMP) as covered in FDA's 21 CFR 110.80. The number of highly publicized food recalls has renewed pressure on food businesses to become compliant with FDA 21 CFR Part 11. This requires them to track and trace ingredients, monitor and control key process variables such as temperature and track products as they are shipped. Although using digital recordkeeping and electronic signatures is not currently mandated by the FDA, it expedites record retrieval, saving time and labor. Using software to track food components and hardware to accomplish such tasks as recording temperatures can eliminate mistakes made when humans fail to complete these tasks manually. Using Datex FootPrint ® software streamlines and automates many processes, reduces mistakes, records critical data, and makes information easy to use and access.

Datex FootPrint® utilizes state-of-the-art Microsoft .NET technology to provide a unified WMS solution, built from the ground up, rather than updated from older software. Known for its familiar user interface, it is intuitive, making it easier to learn and to master with minimal training. Providing the ability to allocate items based on FIFO, FMFO, LEFO, LMFO, and FEFO to effectively manage inventory, FootPrint is able to track inventory by lot, SKU, and UPC. The Datex WMS solution includes a labor and time saving barcode parser capable of handling variable weights and ASN receiving. Datex FootPrint® was developed by working closely in concert with cold storage customers as well as with the International Association of Refrigerated Warehouses (IARW) and includes all updated industry standard reports. To ensure a complete solution, Datex customers enjoy the highest standard of professional customer care, service, and support.

Datex will be showcasing the added functionality as part of an online demonstration for qualified attendees. Free webinars will be held on December 1st and December 8th from 2 to 3 pm.

About Datex
Consistently recognized for excellence in software solutions for the supply chain industry including the Inbound Logistics Top 100 IT Providers and Food Logistics FL100 , Datex utilizes the highly flexible Microsoft .NET platform to create a variety of supply chain software solutions to meet the changing needs of warehousing and logistics operations. With successful experience in third party logistics, cold storage, pharmaceutical, perishables and the courier industry, Datex brings the value of state-of-the-art technology and real world industry knowledge to help maximize business efficiency and increase potential revenue. In addition to its core business, Datex offers business process analysis as well as an extensive array of hardware solutions for the supply chain and logistics industry.

### 
 

Contact Information
Datex
Laura Olson
800.933.2839
[email protected]
www.datexcorp.com
 

Suggested Articles

Having only just completed an expansion in Illinois, PCI Pharma Services will now expand its solid dose facility in Wales in the U.K.

With a green light in lung cancer, AstraZeneca's Imfinzi has become the first PD-L1 drug approved in China, ahead of Roche's Tecentriq.

The FDA has come down on a small U.S. drugmaker for taking a skin medication to market even though there were out-of-spec test results at release.